(SYF) Synchrony Financial - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US87165B1035

SYF: Credit Cards, Loans, Deposits, Financing

Synchrony Financial (NYSE:SYF) is a leading consumer financial services company specializing in credit products, banking solutions, and payment technologies. Established in 1932 and headquartered in Stamford, Connecticut, the company operates through subsidiaries to deliver tailored financial services across multiple industries. Its product portfolio includes private label credit cards, co-branded credit cards, installment loans, and deposit products such as CDs, IRAs, and savings accounts. Synchrony also offers debt cancellation products, healthcare financing through CareCredit and Walgreens, and industry-specific payment solutions for retail, auto, telecommunications, and outdoor sectors. The company partners with national and regional retailers, manufacturers, and healthcare providers to distribute its products, leveraging both digital and traditional channels. Synchrony serves a diverse range of industries, including digital, health, home, auto, and pet care.

Technically, SYF is currently trading at $47.23, below its 20-day SMA of $49.66 and 50-day SMA of $55.03. The stocks 200-day SMA stands at $56.20, indicating a downtrend in recent months. The Average True Range (ATR) of 2.88 suggests moderate volatility. On a fundamental basis, Synchronys market cap is $170.31 billion, with a P/E ratio of 5.12 and a forward P/E of 5.84. The price-to-book ratio is 1.11, and the price-to-sales ratio is 1.81. The companys return on equity (RoE) is 21.10%, reflecting strong profitability.

3-Month Forecast: - Technical Outlook: SYFs price is below its key moving averages, signaling bearish momentum. The 20-day SMA crossing below the 50-day SMA suggests continued weakness. Support levels may be tested near $44, with resistance at $52. - Fundamental Outlook: Synchronys low P/E ratio and high RoE indicate undervaluation and strong profitability. Expect moderate revenue growth driven by its healthcare and digital payment segments. The companys focus on partnerships and deposit growth could stabilize performance despite macroeconomic headwinds.

Additional Sources for SYF Stock

SYF Stock Overview

Market Cap in USD 18,609m
Sector Financial Services
Industry Credit Services
GiC Sub-Industry Consumer Finance
IPO / Inception 2014-07-31

SYF Stock Ratings

Growth Rating 69.5
Fundamental 64.8
Dividend Rating 61.6
Rel. Strength -1.61
Analysts 4.13/5
Fair Price Momentum 47.66 USD
Fair Price DCF 270.32 USD

SYF Dividends

Dividend Yield 12m 1.95%
Yield on Cost 5y 6.46%
Annual Growth 5y 2.59%
Payout Consistency 99.5%

SYF Growth Ratios

Growth Correlation 3m -92.4%
Growth Correlation 12m 66.6%
Growth Correlation 5y 53.9%
CAGR 5y 27.10%
CAGR/Max DD 5y 0.58
Sharpe Ratio 12m 0.41
Alpha 3.09
Beta 1.538
Volatility 43.52%
Current Volume 5001.8k
Average Volume 20d 5767.1k
What is the price of SYF stocks?
As of April 26, 2025, the stock is trading at USD 51.42 with a total of 5,001,802 shares traded.
Over the past week, the price has changed by +8.87%, over one month by -7.93%, over three months by -26.13% and over the past year by +17.38%.
Is Synchrony Financial a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Synchrony Financial (NYSE:SYF) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 64.78 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SYF as of April 2025 is 47.66. This means that SYF is currently overvalued and has a potential downside of -7.31%.
Is SYF a buy, sell or hold?
Synchrony Financial has received a consensus analysts rating of 4.13. Therefor, it is recommend to buy SYF.
  • Strong Buy: 10
  • Buy: 6
  • Hold: 7
  • Sell: 0
  • Strong Sell: 0
What are the forecast for SYF stock price target?
According to ValueRays Forecast Model, SYF Synchrony Financial will be worth about 54.8 in April 2026. The stock is currently trading at 51.42. This means that the stock has a potential upside of +6.55%.
Issuer Forecast Upside
Wallstreet Target Price 66.6 29.6%
Analysts Target Price 74.3 44.5%
ValueRay Target Price 54.8 6.6%